Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007

Bone Loss Clinical Trial

Official title:

Screening of Menstrual Disorder in Elite Feamle Athlete in Iran

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01183377
• Other study ID #: 85-01-41-3488
• Status: Terminated
• Phase: N/A
• First received: August 13, 2010
• Last updated: August 16, 2010
• Start date: October 2006
• Est. completion date: March 2009

Study information

• Verified date: August 2010
• Source: Tehran University of Medical Sciences
• Contact: n/a
• Is FDA regulated: No
• Health authority: Iran: Ethics Committee
• Study type: Observational

Clinical Trial Summary

Women's evermore presence in professional and athletic sports has revealed sound evidence on the existence of female athlete triad among the world's elite female athletes. This triad consists of eating disorders, amenorrhea and osteoporosis. It has been stated that all female athletes are potentially at risk, but it is not clear to what extent those exercising at different levels are at risk of this syndrome/triad. Since the manifestation of this triad is often denied, or under-reported, appropriate screening methods are required to identify the symptoms. There is still no clear-cut information available on the incidence of this triad in Iran. And there are religious and cultural differences between Iran's elite female athletes and those in other countries. Therefore, in order to meet Iranian female athletes' needs, the investigators decided to determine the frequency of the female athlete triad in Iran.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 250
• Est. completion date: March 2009
• Est. primary completion date: February 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 13 Years to 45 Years

Eligibility

Inclusion Criteria:

• All Elite Female athletes who play in international teams in sport federation or champion Team in Tehran between 13-45 years old.

Exclusion Criteria:

• The 13-15 year old female athletes who are not manarch with secondary sex charactristics.

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Bone Loss
• Eating Disorder
• Eating Disorders
• Menstruation Disturbances

Locations

Country	Name	City	State
Iran, Islamic Republic of	Rheumatology Research Center, Shariati Hospital	Tehran

Sponsors (1)

Lead Sponsor	Collaborator
Tehran University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of Female Athlete Triad among Elite female athlete in Iran in 2006		24 month	Yes
Secondary	prevalence of menstrual disorder in female athlete in Iran in 2006		24 month	Yes